$1.04 Billion is the total value of Rhenman & Partners Asset Management AB's 93 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 22.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Buy | UNITED HEALTH GROUP INC | $53,625,078 | +167.7% | 105,300 | +160.0% | 5.15% | +171.1% |
| ANTM | Buy | ELEVANCE HEALTH INC | $46,491,588 | +29.0% | 85,800 | +23.5% | 4.46% | +30.7% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $45,820,950 | +15.0% | 595,000 | +2.2% | 4.40% | +16.4% |
| LLY | Sell | LILLY ELI & CO | $42,552,860 | +1.0% | 47,000 | -13.2% | 4.08% | +2.3% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $33,632,960 | +1.9% | 32,000 | -6.7% | 3.23% | +3.2% |
| ABBV | Sell | ABBVIE INC | $32,417,280 | -6.1% | 189,000 | -0.3% | 3.11% | -4.9% |
| THC | Sell | TENET HEALTHCARE CORP | $30,463,870 | -23.7% | 229,000 | -39.7% | 2.92% | -22.7% |
| OSCR | Buy | OSCAR HEALTH INCcl a | $30,162,586 | +19.9% | 1,906,611 | +12.7% | 2.90% | +21.5% |
| Buy | COOPER COS INC | $27,063,000 | -11.4% | 310,000 | +3.0% | 2.60% | -10.3% | |
| ISRG | Buy | INTUITIVE SURGICAL INC | $26,913,425 | +33.5% | 60,500 | +19.8% | 2.58% | +35.3% |
| Sell | PROCEPT BIOROBOTICS CORP | $26,879,600 | +11.7% | 440,000 | -9.7% | 2.58% | +13.2% | |
| BDX | Sell | BECTON DICKINSON & CO | $26,409,230 | -8.0% | 113,000 | -2.6% | 2.54% | -6.8% |
| HCA | Sell | HCA HEALTHCARE INC | $26,344,960 | -21.0% | 82,000 | -18.0% | 2.53% | -20.0% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $25,310,880 | +7.2% | 54,000 | -4.4% | 2.43% | +8.6% |
| CI | Sell | THE CIGNA GROUP | $24,518,707 | -50.8% | 74,171 | -45.9% | 2.35% | -50.1% |
| MRK | Sell | MERCK & CO. INC | $21,665,000 | -24.9% | 175,000 | -19.9% | 2.08% | -23.9% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $20,776,500 | +228.7% | 85,500 | +102.1% | 2.00% | +233.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $20,705,995 | -0.2% | 251,500 | +5.9% | 1.99% | +1.1% |
| BIIB | Buy | BIOGEN INC | $19,658,336 | +60.5% | 84,800 | +49.3% | 1.89% | +62.5% |
| MCK | Sell | MCKESSON CORP | $17,521,200 | -25.8% | 30,000 | -31.8% | 1.68% | -24.9% |
| NTRA | Sell | NATERA INC | $17,001,530 | -22.5% | 157,000 | -34.6% | 1.63% | -21.5% |
| MDT | Sell | MEDTRONIC PLC | $16,371,680 | -42.2% | 208,000 | -36.0% | 1.57% | -41.5% |
| GILD | Buy | GILEAD SCIENCES INC | $16,363,485 | +75.9% | 238,500 | +87.8% | 1.57% | +78.1% |
| ABT | Sell | ABBOTT LABS | $15,066,950 | -28.3% | 145,000 | -21.6% | 1.45% | -27.4% |
| RPRX | ROYALTY PHARMA PLC | $14,363,660 | -13.2% | 544,697 | 0.0% | 1.38% | -12.1% | |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $13,839,414 | -3.6% | 1,232,361 | +6.5% | 1.33% | -2.4% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $13,640,795 | -16.8% | 56,500 | +13.0% | 1.31% | -15.7% |
| DXCM | Sell | DEXCOM INC | $13,265,460 | -30.9% | 117,000 | -15.5% | 1.27% | -30.0% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $13,272,000 | +75.7% | 24,000 | +84.6% | 1.27% | +77.9% |
| CNC | Buy | CENTENE CORP DEL | $13,159,357 | +30.0% | 198,482 | +53.9% | 1.26% | +31.6% |
| ALHC | Sell | ALIGNMENT HEALTHCARE INC | $12,836,123 | +27.9% | 1,641,448 | -18.9% | 1.23% | +29.5% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $12,167,220 | -31.1% | 114,000 | -22.3% | 1.17% | -30.3% |
| DHR | Buy | DANAHER CORPORATION | $12,117,725 | +341.1% | 48,500 | +340.9% | 1.16% | +347.3% |
| ABC | Buy | CENCORA INC | $11,602,950 | +12.4% | 51,500 | +21.2% | 1.11% | +13.8% |
| CYTK | CYTOKINETICS INC | $10,701,363 | -22.7% | 197,515 | 0.0% | 1.03% | -21.7% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $10,401,657 | +27.8% | 75,555 | +28.1% | 1.00% | +29.6% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $10,271,800 | -10.4% | 127,600 | -11.1% | 0.99% | -9.2% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $9,725,580 | +2.2% | 142,000 | +3.3% | 0.93% | +3.5% |
| PODD | Buy | INSULET CORP | $9,383,700 | +57.5% | 46,500 | +33.8% | 0.90% | +59.5% |
| EW | New | EDWARDS LIFESCIENCES CORP | $9,006,075 | – | 97,500 | +100.0% | 0.86% | – |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $7,424,240 | -23.8% | 26,500 | -27.4% | 0.71% | -22.8% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $7,378,400 | -47.9% | 920,000 | -3.7% | 0.71% | -47.2% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $7,023,720 | +104.1% | 34,000 | +167.7% | 0.67% | +106.7% |
| INSM | New | INSMED INC | $6,667,371 | – | 99,513 | +100.0% | 0.64% | – |
| IQV | IQVIA HLDGS INC | $6,554,640 | -16.4% | 31,000 | 0.0% | 0.63% | -15.3% | |
| Sell | NUVALENT INC | $6,277,415 | -4.5% | 82,750 | -5.4% | 0.60% | -3.2% | |
| IONS | New | IONIS PHARMACEUTICALS INC | $6,195,800 | – | 130,000 | +100.0% | 0.60% | – |
| ARVN | Buy | ARVINAS INC | $6,122,600 | -12.8% | 230,000 | +35.3% | 0.59% | -11.6% |
| SYK | Buy | STRYKER CORPORATION | $6,124,500 | +113.9% | 18,000 | +125.0% | 0.59% | +117.0% |
| EXAS | Buy | EXACT SCIENCES CORP | $6,126,250 | -38.0% | 145,000 | +1.4% | 0.59% | -37.2% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $6,096,150 | -48.7% | 115,000 | -20.7% | 0.58% | -48.1% |
| GKOS | Buy | GLAUKOS CORP | $5,917,500 | +132.4% | 50,000 | +85.2% | 0.57% | +135.7% |
| MRUS | New | MERUS N V | $5,354,885 | – | 90,500 | +100.0% | 0.51% | – |
| EHC | Buy | ENCOMPASS HEALTH CORP | $5,147,400 | +114.9% | 60,000 | +106.9% | 0.49% | +117.6% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $4,691,105 | +10.4% | 228,500 | +28.0% | 0.45% | +11.7% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $4,673,385 | +44.6% | 184,500 | +76.6% | 0.45% | +46.7% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $4,590,008 | +98.1% | 134,250 | +45.5% | 0.44% | +100.5% |
| JANX | Buy | JANUX THERAPEUTICS INC | $4,475,821 | +13.8% | 106,847 | +2.2% | 0.43% | +15.3% |
| ANNX | New | ANNEXON INC | $4,410,000 | – | 900,000 | +100.0% | 0.42% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $4,384,500 | – | 1,975,000 | +100.0% | 0.42% | – |
| EPIX | Sell | ESSA PHARMA INC | $4,239,844 | -45.2% | 806,054 | -11.6% | 0.41% | -44.6% |
| XNCR | XENCOR INC | $4,140,938 | -14.5% | 218,750 | 0.0% | 0.40% | -13.3% | |
| PEN | Sell | PENUMBRA INC | $4,139,310 | -59.7% | 23,000 | -50.0% | 0.40% | -59.2% |
| TGTX | Buy | TG THERAPEUTICS INC | $3,798,165 | +102.2% | 213,500 | +72.9% | 0.36% | +105.1% |
| NRIX | New | NURIX THERAPEUTICS INC | $3,639,582 | – | 174,393 | +100.0% | 0.35% | – |
| ALKS | Buy | ALKERMES PLC | $3,615,000 | +21.4% | 150,000 | +36.4% | 0.35% | +23.0% |
| KRYS | KRYSTAL BIOTECH INC | $3,489,160 | +3.2% | 19,000 | 0.0% | 0.34% | +4.7% | |
| IMVT | Buy | IMMUNOVANT INC | $3,445,200 | -15.0% | 130,500 | +4.0% | 0.33% | -13.8% |
| KURA | KURA ONCOLOGY IN | $3,428,770 | -3.5% | 166,526 | 0.0% | 0.33% | -2.4% | |
| STAA | New | STAAR SURGICAL CO CALL | $3,094,650 | – | 65,000 | +100.0% | 0.30% | – |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY INC | $2,689,713 | +169.0% | 39,824 | +215.5% | 0.26% | +171.6% |
| INSP | Sell | INSPIRE MED SYS INC | $2,275,110 | -74.8% | 17,000 | -59.5% | 0.22% | -74.5% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $2,124,952 | -79.7% | 55,395 | -68.9% | 0.20% | -79.5% |
| MOH | New | MOLINA HEALTHCARE INC | $2,081,100 | – | 7,000 | +100.0% | 0.20% | – |
| TMDX | New | TRANSMEDICS GROUP INC | $2,033,370 | – | 13,500 | +100.0% | 0.20% | – |
| PRVA | PRIVIA HEALTH GROUP INC | $1,981,320 | -11.3% | 114,000 | 0.0% | 0.19% | -10.4% | |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $1,975,041 | -61.9% | 58,278 | -26.9% | 0.19% | -61.3% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $1,878,385 | – | 53,500 | +100.0% | 0.18% | – |
| RVNC | REVANCE THERAPEUTICS INC | $1,803,387 | -47.8% | 701,707 | 0.0% | 0.17% | -47.1% | |
| INMB | INMUNE BIO INC | $1,572,465 | -24.9% | 178,284 | 0.0% | 0.15% | -24.1% | |
| RLAY | RELAY THERAPEUTICS INC | $1,499,600 | -21.4% | 230,000 | 0.0% | 0.14% | -20.4% | |
| TECH | Buy | BIO-TECHNE CORP | $1,433,000 | +27.2% | 20,000 | +25.0% | 0.14% | +29.0% |
| XENE | New | XENON PHARMACEUTICALS INC | $1,364,650 | – | 35,000 | +100.0% | 0.13% | – |
| IGMS | IGM BIOSCIENCES INC | $1,339,650 | -28.8% | 195,000 | 0.0% | 0.13% | -27.5% | |
| AMGN | AMGEN INC | $1,327,913 | +9.9% | 4,250 | 0.0% | 0.13% | +10.4% | |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $1,292,688 | -40.3% | 120,250 | -17.2% | 0.12% | -39.5% |
| AVTR | Sell | AVANTOR INC | $1,272,000 | -70.9% | 60,000 | -64.9% | 0.12% | -70.5% |
| RGEN | Buy | REPLIGEN CORP | $1,260,600 | +37.1% | 10,000 | +100.0% | 0.12% | +39.1% |
| MEDP | New | MEDPACE HLDGS INC | $1,029,625 | – | 2,500 | +100.0% | 0.10% | – |
| EVH | New | EVOLENT HEALTH INCcl a | $956,000 | – | 50,000 | +100.0% | 0.09% | – |
| NARI | Sell | INARI MED INC | $963,000 | -64.4% | 20,000 | -64.6% | 0.09% | -64.2% |
| AUGX | Buy | AUGMEDIX INC | $880,000 | -73.1% | 1,000,000 | +25.0% | 0.08% | -72.9% |
| BRKR | Sell | BRUKER CORP | $382,860 | -79.6% | 6,000 | -70.0% | 0.04% | -79.2% |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -48,000 | -100.0% | -0.12% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -85,500 | -100.0% | -0.32% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -495,307 | -100.0% | -0.73% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -67,500 | -100.0% | -0.84% | – |
| SWAV | Exit | SHOCKWAVE MEDICAL INC | $0 | – | -64,000 | -100.0% | -1.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 43 | Q2 2024 | 5.1% |
| BIOMARIN PHARMACEUTICAL INC | 43 | Q2 2024 | 5.0% |
| ALKERMES PLC | 43 | Q2 2024 | 3.3% |
| LILLY ELI & CO | 42 | Q2 2024 | 5.8% |
| INTRA-CELLULAR THERAPIES INC | 42 | Q2 2024 | 2.4% |
| VERTEX PHARMACEUTICALS INC | 41 | Q2 2024 | 4.3% |
| REVANCE THERAPEUTICS INC | 41 | Q2 2024 | 0.9% |
| ABBVIE INC | 40 | Q2 2024 | 4.4% |
| CVS HEALTH CORP | 40 | Q4 2023 | 3.5% |
| JAZZ PHARMACEUTICALS PLC | 40 | Q2 2024 | 3.1% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-13 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.